Demographic and Clinical Characteristics of Chronic Myeloid Leukemia Patients: A Study on Confined Populations of Southern India

被引:1
|
作者
Gone, Manjula [1 ]
Sashidhar, R. B. [1 ]
Annamaneni, Sandhya [2 ]
Digumarti, Raghunadharao [3 ]
Satti, Vishnupriya [2 ]
机构
[1] Osmania Univ, Univ Coll Sci, Dept Biochem, Hyderabad, Telangana, India
[2] Osmania Univ, Univ Coll Sci, Dept Genet, Hyderabad 500007, Telangana, India
[3] Nizams Inst Med Sci, Dept Med Oncol, Hyderabad, Telangana, India
关键词
Chronic myeloid leukemia; clinical variable; epidemiology; imatinib mesylate; survival; SURVIVAL; RISK; CHLORPYRIFOS; GENDER; CML;
D O I
10.4103/ijmpo.ijmpo_141_17
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Context: Chronic myeloid leukemia (CML) is one of the most common hematological malignancies in all populations throughout the world. Even though the pathophysiology of CML was well explained in majority of the studies, the incidence of CML was shown to exhibit population diversity, and hence, the demographic factors underlying CML origin remain to be understood. Further, the introduction of tyrosine kinase inhibitors had revolutionized the treatment of CML over the years; however, there is a need for developing tailoring therapy to individual risk since the patient clinical heterogeneity poses a major problem during drug response. Therefore, the study of basic clinical picture may aid in planning treatment strategies for CML patients. Aim: The aim of this article is to study the epidemiological and clinical variables associated with the prognosis of CML. Subjects and Methods: We have considered the distribution of various demographic and clinical variables among 476 CML patients diagnosed at Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India. Statistical Analysis Used: All the analyses were performed through SPSS software (version 21.0). Correlation and Cox regression analyses were also performed. Results: Apart from the elevated male sex ratio in CML incidence, high frequency of males was observed to be nonresponders to imatinib mesylate (IM). IM response was shown to be dependent on phase of diagnosis, whereas overall survival of CML patients depends on the age at onset and response to IM. Conclusions: The study of epidemiology and clinical picture of CIVIL patients may help in planning better treatment strategies at diagnosis to achieve long-term progression-free survival.
引用
收藏
页码:S70 / S76
页数:7
相关论文
共 50 条
  • [21] Clinical characteristics,treatment pattern,and outcomes in newly diagnosed patients with chronic myeloid leukemia in the chronic phase by age
    彭楠
    [J]. China Medical Abstracts (Internal Medicine), 2021, 38 (02) : 120 - 120
  • [22] Comparison of the efficacy and safety of Chinese generic imatinib and branded imatinib in patients with chronic myeloid leukemia in consideration of demographic characteristics
    窦雪琳
    [J]. China Medical Abstracts (Internal Medicine), 2020, 37 (01) : 59 - 60
  • [23] Chronic myeloid leukemia data from India
    Bansal, Shweta
    Prabhash, Kumar
    Parikh, Purvish
    [J]. INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2013, 34 (03) : 154 - 158
  • [24] Secondary Acute Myeloid Leukemia: Demographic, Physiopathogenic, Clinical and Therapeutic Comparative Study
    Ovilla, Roberto
    Leonor Crisp, Renee
    Baez-Islas, Pamela E.
    Arbelbide, Jorge A.
    Grille, Sofia
    Diaz, Lilian
    Idrobo, Henry
    Enrico, Alicia
    Mela Osorio, Maria J.
    Fernandez, Isolda I.
    Ferrari, Luciana C.
    Zapata, Nidia
    Ceballos-Lopez, Adrian A.
    Mena, Veronica
    Romero, Ana L.
    Serrano, Juan Carlos
    Vidal-Senmache, Gabriela
    Barroso Duarte, Fernando
    Pintos, Edit N.
    Rosenhain, Mariana
    Kornblihtt, Laura
    Tejeira, Natalia
    Gusmao, Breno
    Del Rocio Buenano, Maria Elena
    Di Stefano, Marcos
    Boada, Matilde
    Gimenez Conca, Alberto
    Perusini, Maria
    Dick, Hernan
    Cranco, Santiago
    Lucia Fuente, Maria
    Beatriz Navickas, Alicia
    Moirano, Maria M.
    Oliveira, Natalia
    Gonzalez, Jacqueline
    Bandin, Mariana
    Villaverde, Noelia
    Suero, Alejandro
    Felipe Lasso, Juan
    Carrara, Nora
    Cota, Xochitl
    Lazzarino, Carolina
    Leticia Rapan, Maria
    Iastrebner, Marcelo
    [J]. BLOOD, 2019, 134
  • [25] CLINICAL, HEMATOLOGICAL, BIOLOGIC AND MOLECULAR CHARACTERISTICS IN PATIENTS WHO DEVELOP ACUTE MYELOID LEUKEMIA FROM CHRONIC MYELOMONOCYTIC LEUKEMIA
    Geissler, K.
    Barna, A.
    Jaeger, E.
    Alendar, T.
    Ljubuncic, E.
    Jilch, R.
    Noesslinger, T.
    Pfeilstoecker, M.
    Tuechler, H.
    Reisner, R.
    Sliwa, T.
    Keil, F.
    Burgstaller, S.
    Thaler, J.
    Machherndl-Spandl, S.
    Zach, O.
    Weltermann, A.
    Bettelheim, P.
    Stauder, R.
    Schwarzinger, I.
    Hoermann, G.
    Gabriel, C.
    Jaeger, U.
    Sperr, W. R.
    Knoebl, P.
    Schneeweiss, B.
    Berger, J.
    Kusec, R.
    Valent, P.
    [J]. HAEMATOLOGICA, 2016, 101 : 204 - 205
  • [26] CLINICAL ASPECTS OF NILOTINIB USE IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN THE CHRONIC PHASE
    Gusarova, G. A.
    Turkina, A. G.
    Kolosheinova, T. I.
    Vakhrusheva, M. V.
    Chelysheva, E. Yu.
    Zakharova, E. S.
    Kuznetsov, S. V.
    Nemchenko, I. S.
    Sokolova, M. A.
    Goryacheva, S. R.
    Lazareva, O. V.
    Bykova, A. V.
    Tkhai, N. V.
    Khoroshko, N. D.
    [J]. GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2012, 57 (04): : 3 - 11
  • [27] Clinical Application of Artificial Intelligence in Patients with Chronic Myeloid Leukemia in Chronic Phase
    Sasaki, Koji
    Kantarjian, Hagop M.
    Jabbour, Elias J.
    O'Brien, Susan
    Ravandi, Farhad
    Konopleva, Marina
    Borthakur, Gautam
    Wierda, William G.
    Daver, Naval
    Takahashi, Koichi
    Jain, Preetesh
    Skinner, Jeffrey
    Rios, Mary Beth
    Pierce, Sherry
    Garcia-Manero, Guillermo
    Cortes, Jorge E.
    [J]. BLOOD, 2016, 128 (22)
  • [28] Clinical Trials in Chronic Myeloid Leukemia
    Saussele, Susanne
    Pfirrmann, Markus
    [J]. CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2012, 7 (02) : 109 - 115
  • [29] Clinical Trials in Chronic Myeloid Leukemia
    Susanne Saussele
    Markus Pfirrmann
    [J]. Current Hematologic Malignancy Reports, 2012, 7 : 109 - 115
  • [30] Hyperleukocytosis in Pediatric Patients with Acute Lymphoblastic Leukemia: Demographic and Clinical Characteristics
    Mitura-Lesiuk, Malgorzata Monika
    Dubaj, Maciej
    Dembowska, Aleksandra
    Bigosinski, Karol
    Raniewicz, Mateusz
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (17)